Guest: Ammar Killu, M.B.B.S.
Host: Sharonne Hayes, M.D.
Overview:
In today’s episode of “Interviews With the Experts, listeners will learn how to select patients that may benefit from left atrial appendage occlusion. Listeners will understand the major differences between currently available commercial devices.
Topics Discussed:
• What is left atrial appendage closure?
• Who may benefit from left atrial appendage closure and is there expansion of indications?
• What devices are currently approved for LAA closure? Are there any newer devices on the horizon?
• What are the post device anticoagulation/ antithrombotic regimens?
From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Host: Sharonne Hayes, M.D.
Overview:
In today’s episode of “Interviews With the Experts, listeners will learn how to select patients that may benefit from left atrial appendage occlusion. Listeners will understand the major differences between currently available commercial devices.
Topics Discussed:
• What is left atrial appendage closure?
• Who may benefit from left atrial appendage closure and is there expansion of indications?
• What devices are currently approved for LAA closure? Are there any newer devices on the horizon?
• What are the post device anticoagulation/ antithrombotic regimens?
From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
- Category
- Cardiology

Be the first to comment